1. ECHA
  2. Julkiset kuulemiset
  3. Lupahakemukset

Lupahakemukset

Lupahakemukset

The application for authorisation process includes a period of public consultation. It lasts for eight weeks.

 

Instructions for providing comments

Anyone can provide information on alternative substances or technologies for the uses of Annex XIV substances included in applications for authorisation. Those most likely to be interested are companies, organisations representing industry or civil society, individual citizens, as well as public authorities.

The following documents describe the public consultation process:

 

Document Description  
Submission of information on alternatives Instructions of how interested third parties can submit information for the public consultation on alternatives for applications for authorisation. Download
Format for "Public version" Download
Format for "Complete version" Download

 

 

Provide your comments

In order to facilitate the work of ECHA's Committees in reviewing the comments received, you are kindly invited to provide your comments in English preferably. By clicking on a link in the table below, you will get access to the full broad information on the use applied for, and to the related commenting form. Comments are welcomed from the EU or beyond.

Consultations close at 23:59 Helsinki time (EET).

Adopted opinions and previous consultations on applications for authorisation

 

Related Links

 

Näytetään 18 tulosta.
ID
Application type
Name
EC Number
CAS Number
Deadline for consultation
Applicant(s)
Use name
 
0135-01 Initial Chromium trioxide 215-607-8 1333-82-0 17/07/2019 Thyssenkrupp Electrical Steel GmbH;
Thyssenkrupp Electrical
Steel UGO S.A.S.
 Surface treatment for the manufacture of grain-oriented electrical steel used in magnetic circuits of electric devices, in particular magnetic cores of high-performance transformers
0136-01 Initial Sodium chromate 231-889-5 7775-11-3 17/07/2019 Ariston Thermo SpA Use of sodium chromate as an anticorrosion agent of the carbon steel in sealed circuit of gas absorption appliances up to 0.70% by weight (as Cr6+) in the refrigerant solution
0137-01 Initial Sodium dichromate 234-190-3
10588-01-9
7789-12-0
 17/07/2019 SOCIETA' CHIMICA BUSSI S.P.A. Use of sodium dichromate as an additive for suppressing parasitic reactions and oxygen evolution, pH buffering and cathode corrosion protection in the electrolytic manufacturing of sodium chlorite.
0138-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 Boehringer Ingelheim Pharma
GmbH & Co. KG; Boehringer
Ingelheim RCV GmbH & Co KG 		Use of 4-tert-OPnEO in a washing buffer to purify biological APIs (active pharmaceutical ingredients) during the production of Palivizumab and Moxetumomab pasudotox-tdfk.
0139-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 Ortho-Clinical Diagnostics Formulation of 4-(1,1,3,3-Tetramethylbutyl) phenol, ethoxylated (as Triton X-100) for use in the manufacture of in vitro diagnostic VITROS® products used for infectious disease screening, endocrinology, and oncology testing.
0139-02 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 Ortho-Clinical Diagnostics Use of 4-(1,1,3,3-Tetramethylbutyl) phenol, ethoxylated (as Triton X-100) in two in vitro diagnostic VITROS® products used by professional diagnostic laboratories to detect antibodies to human hepatitis A virus and IgG antibodies to rubella virus.
0140-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 DIAGNOSTICA STAGO Industrial use of 4-tert-OPnEO for its detergent properties in the process of cell lysing for the production of in-vitro diagnostic reagents (Asserachrom® HPIA, Asserachrom® HPIA–IgG and Asserachrom® PF4 and STA®-Néoplastine® R15 assays).
0140-02 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 DIAGNOSTICA STAGO Industrial use of 4-tert-OPnEO in view of controlling the amount of non-specific reactions in the production of in-vitro diagnostic reagents (STA® - Liatest® D-Di assays).
0141-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 SEBIA Industrial use of 4-tert-OPnEO for its wetting detergent properties in the production of buffers, reagents and gel supports allowing the dissolution, the dilution and the good spreading of substrates and reagents, necessary to optimize the functioning and the sensitivity of gel electrophoresis in vitro diagnostic tests.
0141-02 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 SEBIA Industrial use of 4-tert-OPnEO for its detergent properties in the production of electrophoresis gels in view of ensuring the positioning of specific proteins necessary for the interpretation of results of gel electrophoresis in vitro diagnostic tests.
0141-03 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 SEBIA Industrial use of 4-tert-OPnEO for its detergent properties resulting in cellular lysis and protein interactions rupture and required for the production of reagents involved in the determination of proteins of interest in gel and capillary electrophoresis IVD tests.
0142-01 Initial 4-Nonylphenol, branched and linear, ethoxylated - - 17/07/2019 SEBIA Industrial use of 4-NPnEO for its detergent properties in the production of buffers and reagents in view of ensuring the positioning of specific proteins necessary for the interpretation of gel electrophoresis in vitro diagnostic tests results based on the determination of isoenzymes.
0143-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 bioMérieux SA Industrial use of 4-tert-OPnEO for its non-ionic detergent properties in the formulation of reagents for molecular clinical and industrial in vitro preparative and testing applications.
0143-02 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 bioMérieux SA Industrial use of 4-tert-OPnEO for its non-ionic detergent to control the level of non-specific reactions in the formulation of in vitro reagents for clinical and industrial in vitro testing immunoassays.
0143-03 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 bioMérieux SA Industrial use of 4-tert-OPnEO for its detergent properties, used for the extraction of biological material which is further formulated and intended for clinical and industrial in vitro testing applications.
0144-01 Initial Pitch, coal tar, high-temp 266-028-2 65996-93-2 17/07/2019 ArianeGroup SAS Industrial use of pitch, coal tar, high temp. as precursor of carbon matrix in the manufacturing of thermally and thermo-mechanically highly loaded carbon/carbon parts including nozzle throats and other critical carbon-carbon composite parts, resistant to very harsh erosion conditions, and very high temperature ranges, dedicated to high-performance civilian and military aerospace launchers.
0145-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 BioMarin International Limited Industrial use as a surfactant to perform viral inactivation of biological proteins in the manufacture of a biopharmaceutical Final Bulk Drug Substance (FBDS) for an Enzyme Replacement Therapy (BMN250) for the treatment of Mucopolysaccharidosis IIIB (MPS IIIB).
0145-02 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - 17/07/2019 BioMarin International Limited Industrial use as a surfactant to perform viral inactivation of biological proteins in the manufacture of a biopharmaceutical Final Bulk Drug Substance (FBDS) for Gene Therapy products for the treatment of rare conditions in the human population.
Näytetään 18 tulosta.



 

 

Related links

 

Categories Display

Avainsana:

(klikkaa avainsanaa päästäksesi sitä koskevaan sisältöön)


Route: .live2